CN103100010A - Drug for treatment of rheumatic arthritis - Google Patents

Drug for treatment of rheumatic arthritis Download PDF

Info

Publication number
CN103100010A
CN103100010A CN2013100534254A CN201310053425A CN103100010A CN 103100010 A CN103100010 A CN 103100010A CN 2013100534254 A CN2013100534254 A CN 2013100534254A CN 201310053425 A CN201310053425 A CN 201310053425A CN 103100010 A CN103100010 A CN 103100010A
Authority
CN
China
Prior art keywords
drug
rheumatic arthritis
grams
medicine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013100534254A
Other languages
Chinese (zh)
Inventor
武瑞美
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2013100534254A priority Critical patent/CN103100010A/en
Publication of CN103100010A publication Critical patent/CN103100010A/en
Priority to CN201310647066.5A priority patent/CN103610982B/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a drug for treatment of rheumatic arthritis. The drug is characterized in that it is a granule, a tablet or a capsule made from the following raw material drugs by weight: 2-4 of masson pine bark, 1.5-2.5 of field thistle, 2.3-3.5 of white paeony roots, 2-4 of roots of sageretia theezans, 1.5-2.5 of honeysuckle, 2-4 of panax notoginseng, 1.5-2.5 of sodium bicarbonate, 2-4 of Rhizoma Heterosmilacis Japonicae, 1.5-2.5 of radix rehmanniae, and 1.5-2.5 of eleusine indica. The drug provided in the invention is used for treating rheumatic arthritis, and after taking it, a good curative effect can be achieved. The drug has the efficacy of joint swelling reducing, pain relieving, and joint function recovery and improvement, etc. Through preliminary clinical verification, the drug has a rheumatic arthritis cure rate up to 96.5% and an effective rate of 100%. In addition, the drug also has the characteristics of easily available medicinal raw materials, and convenient administration, etc.

Description

A kind of medicine for the treatment of rheumatic arthritis
Technical field
The present invention relates to a kind of Chinese medicine preparation that is used for the treatment of rheumatic arthritis.
Background technology
Rheumatic arthritis is a kind of commonly encountered diseases and frequently-occurring disease.At present, doctor trained in Western medicine uses the medicines such as glucocorticoids, immunosuppressant that this disease is treated more, though certain curative effect is arranged, therapeutic effect is unsatisfactory, and such medicine also has suitable toxic and side effects, and life-time service is larger to patient's harm.Through a large amount of clinical verifications, though Chinese medicine decoction has certain therapeutic effect for treatment rheumatic arthritis, but decoction decocting is cumbersome, and the patient is difficult to adhere to for a long time taking.In addition, also there are clinically a large amount of Chinese medicine preparation to be applied to treat rheumatic arthritis, therapeutic effect is different, this class Chinese medicine preparation has various dosage forms, but medicament or the raw material of Chinese medicine of employing compatibility are nearly more than tens kinds mostly, the manufacturing process very complex is so just applied to it and has been brought many restrictions.
Summary of the invention
Task of the present invention is to provide a kind of medicine for the treatment of rheumatic arthritis, and this medicine realizes that determined curative effect, medicine material are simple and easy to, and taking convenience.
Its technical solution is:
A kind of medicine for the treatment of rheumatic arthritis, granule, tablet or the capsule made by the crude drug of following weight portion:
Horse hair Cortex Pini Massonianae 2~4, Herba Cirsii 1.5~2.5, the Radix Paeoniae Alba 2.3~3.5, Sageretia theezans root 2~4, Flos Lonicerae 1.5~2.5, Radix Notoginseng 2~4, sodium bicarbonate 1.5~2.5, hargil Poria 2~4, Radix Rehmanniae 1.5~2.5, Herba Eleusines Indicae 1.5~2.5.
As a kind of preferred technical scheme, a kind of medicine for the treatment of rheumatic arthritis, granule, tablet or the capsule made by the crude drug of following weight portion:
Horse hair Cortex Pini Massonianae 3, Herba Cirsii 2, the Radix Paeoniae Alba 2.5, Sageretia theezans root 3, Flos Lonicerae 2, Radix Notoginseng 3, sodium bicarbonate 2, hargil Poria 3, Radix Rehmanniae 2, Herba Eleusines Indicae 2.
The present invention can be made into granule, capsule or tablet, and Coming-of-Age Day takes three times, each serving with 5~10 grams.
Pharmacology analysis: the horse hair Cortex Pini Massonianae in the present invention, namely the dried bark of Pinus massoniana Lamb, have wind-damp dispelling, blood circulation promoting and blood stasis dispelling, pain relieving, hemostasis, the loose effect that swells and ache; Herba Cirsii, another name claims field thistle, luxuriant dish etc., has the effect of cooling blood for hemostasis, removing blood stasis to reduce swelling; The Radix Paeoniae Alba has except effects such as arthralgia due to stagnation of blood, broken heavily fortified point amass, pain relieving, QI invigorating; The Sageretia theezans root has the effects such as wind-damp dispelling, benefit muscles and bones; Flos Lonicerae has the effects such as dispelling wind-heat, removing summer-heat blood poison; Radix Notoginseng has the effects such as dissipating blood stasis hemostasis, subduing swelling and relieving pain; Sodium bicarbonate is weak base, can be rapidly after for oral administration in and gastric acid, a little less than its antiacid effect and of short duration; The hargil Poria has the effects such as detoxifcation dehumidifying, easing joint movement; Radix Rehmanniae has clearing away heat and cooling blood, the effects such as YIN nourishing and the production of body fluid promoting; Herba Eleusines Indicae has the effects such as heat clearing away, dampness removing.Above-mentioned Ten Herbs and use can have the detoxifcation dehumidifying, strong muscles and bones, and reducing swelling and alleviating pain, easing joint movement, the effects such as expelling wind and removing dampness have curative effect preferably for treatment rheumatic arthritis.
The present invention is used for the treatment of rheumatic arthritis, takes the rear curative effect preferably that all has, and has that arthroncus is disappeared, pain relief, and joint functional recovery improvement texts.Through the clinical principium checking, can reach 96.5% for the rheumatic arthritis cure rate, effective percentage is 100%.In addition, also have medicine material and be simple and easy to, and the characteristics such as taking convenience.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of medicine for the treatment of rheumatic arthritis, the granule of being made by the crude drug of following weight portion:
Horse hair Cortex Pini Massonianae 2, Herba Cirsii 1.5, the Radix Paeoniae Alba 2.3, Sageretia theezans root 2, Flos Lonicerae 1.5, Radix Notoginseng 2, sodium bicarbonate 1.5, hargil Poria 2, Radix Rehmanniae 1.5, Herba Eleusines Indicae 1.5.
Said medicine can adopt following preparation method, and the method comprising the steps of:
A is with horse hair Cortex Pini Massonianae 200 grams, Herba Cirsii 150 grams, the Radix Paeoniae Alba 230 grams, Sageretia theezans root 200 grams, Radix Notoginseng 200 grams, hargil Poria 200 grams and Herba Eleusines Indicae 150 grams, mix, then decoct with water twice, add the water of 10~12 times at every turn, the each decoction 3 hours, decocting liquid filters, and twice filtrate is merged, and mix homogeneously, then heating is concentrated into every ml and is equivalent to crude drug 2 grams.Add ethanol, the ethanol content that adds reaches more than 75% again, after static 12 hours, filters, and reclaims ethanol, obtains solids, and this solids vacuum drying is ground into the extractum fine powder, and is standby.
B is with Flos Lonicerae 150 grams, sodium bicarbonate 150 grams and Radix Rehmanniae 150 grams, mix, then decoct with water twice, add the water of 8~10 times at every turn, the each decoction 2 hours, decocting liquid filters, and twice filtrate is merged, and mix homogeneously, the clear paste of the relative density 1.30~1.50 when then heating is concentrated into 50 ℃.
The clear paste that the extractum fine powder that c obtains step a, step b obtain and maltodextrin are made granulated quickly dissolving according to conventional method, every bag of granule pastille 10 grams in the ratio mix homogeneously of 4:3:2.
Usage: above-mentioned one bag of granule is poured in cup, added 100ml hot water to rush molten, drink-service gets final product; Every day 3 times.
Through the clinical principium checking, the medicine that this example obtains can reach 95.5% for the rheumatic arthritis cure rate.
Embodiment 2
A kind of medicine for the treatment of rheumatic arthritis, the granule of being made by the crude drug of following weight portion:
Horse hair Cortex Pini Massonianae 4, Herba Cirsii 2.5, the Radix Paeoniae Alba 3.5, Sageretia theezans root 4, Flos Lonicerae 2.5, Radix Notoginseng 4, sodium bicarbonate 2.5, hargil Poria 4, Radix Rehmanniae 2.5, Herba Eleusines Indicae 2.5.
Said medicine can adopt following preparation method, and the method comprising the steps of:
A is with horse hair Cortex Pini Massonianae 400 grams, Herba Cirsii 250 grams, the Radix Paeoniae Alba 350 grams, Sageretia theezans root 400 grams, Radix Notoginseng 400 grams, hargil Poria 400 grams and Herba Eleusines Indicae 250 grams, mix, then decoct with water twice, add the water of 10~12 times at every turn, the each decoction 3 hours, decocting liquid filters, and twice filtrate is merged, and mix homogeneously, then heating is concentrated into every ml and is equivalent to crude drug 2 grams.Add ethanol, the ethanol content that adds reaches more than 75% again, after static 12 hours, filters, and reclaims ethanol, obtains solids, and this solids vacuum drying is ground into the extractum fine powder, and is standby.
B is with Flos Lonicerae 250 grams, sodium bicarbonate 250 grams and Radix Rehmanniae 250 grams, mix, then decoct with water twice, add the water of 8~10 times at every turn, the each decoction 2 hours, decocting liquid filters, and twice filtrate is merged, and mix homogeneously, the clear paste of the relative density 1.30~1.50 when then heating is concentrated into 50 ℃.
The clear paste that the extractum fine powder that c obtains step a, step b obtain and maltodextrin are made granulated quickly dissolving according to conventional method, every bag of granule pastille 10 grams in the ratio mix homogeneously of 4:3:2.
Usage: above-mentioned one bag of granule is poured in cup, added 100ml hot water to rush molten, drink-service gets final product; Every day 3 times.
Through the clinical principium checking, the medicine that this example obtains can reach 96% for the rheumatic arthritis cure rate.
Embodiment 3
A kind of medicine for the treatment of rheumatic arthritis, the granule of being made by the crude drug of following weight portion:
Horse hair Cortex Pini Massonianae 3, Herba Cirsii 2, the Radix Paeoniae Alba 2.5, Sageretia theezans root 3, Flos Lonicerae 2, Radix Notoginseng 3, sodium bicarbonate 2, hargil Poria 3, Radix Rehmanniae 2, Herba Eleusines Indicae 2.
Said medicine can adopt following preparation method, and the method comprising the steps of:
A is with horse hair Cortex Pini Massonianae 300 grams, Herba Cirsii 200 grams, the Radix Paeoniae Alba 250 grams, Sageretia theezans root 300 grams, Radix Notoginseng 300 grams, hargil Poria 300 grams and Herba Eleusines Indicae 200 grams, mix, then decoct with water twice, add the water of 10~12 times at every turn, the each decoction 3 hours, decocting liquid filters, and twice filtrate is merged, and mix homogeneously, then heating is concentrated into every ml and is equivalent to crude drug 2 grams.Add ethanol, the ethanol content that adds reaches more than 75% again, after static 12 hours, filters, and reclaims ethanol, obtains solids, and this solids vacuum drying is ground into the extractum fine powder, and is standby.
B is with Flos Lonicerae 200 grams, sodium bicarbonate 200 grams and Radix Rehmanniae 200 grams, mix, then decoct with water twice, add the water of 8~10 times at every turn, the each decoction 2 hours, decocting liquid filters, and twice filtrate is merged, and mix homogeneously, the clear paste of the relative density 1.30~1.50 when then heating is concentrated into 50 ℃.
The clear paste that the extractum fine powder that c obtains step a, step b obtain and maltodextrin are made granulated quickly dissolving according to conventional method, every bag of granule pastille 10 grams in the ratio mix homogeneously of 4:3:2.
Usage: above-mentioned one bag of granule is poured in cup, added 100ml hot water to rush molten, drink-service gets final product; Every day 3 times.
Through the clinical principium checking, the medicine that this example obtains can reach 96.5% for the rheumatic arthritis cure rate.
In addition to the implementation, medicine of the present invention can also be made tablet or capsule.
The relevant technologies content of not addressing in aforesaid way is taked or is used for reference prior art and can realize.
Need to prove, those skilled in the art can also make such or such easy variation pattern under the instruction of this description, such as equivalent way, or obvious mode of texturing.Above-mentioned variation pattern all should be within protection scope of the present invention.

Claims (2)

1. medicine for the treatment of rheumatic arthritis is characterized in that granule, tablet or the capsule made by the crude drug of following weight portion:
Horse hair Cortex Pini Massonianae 2~4, Herba Cirsii 1.5~2.5, the Radix Paeoniae Alba 2.3~3.5, Sageretia theezans root 2~4, Flos Lonicerae 1.5~2.5, Radix Notoginseng 2~4, sodium bicarbonate 1.5~2.5, hargil Poria 2~4, Radix Rehmanniae 1.5~2.5, Herba Eleusines Indicae 1.5~2.5.
2. a kind of medicine for the treatment of rheumatic arthritis according to claim 1 is characterized in that the weight portion proportioning of above-mentioned raw materials medicine is:
Horse hair Cortex Pini Massonianae 3, Herba Cirsii 2, the Radix Paeoniae Alba 2.5, Sageretia theezans root 3, Flos Lonicerae 2, Radix Notoginseng 3, sodium bicarbonate 2, hargil Poria 3, Radix Rehmanniae 2, Herba Eleusines Indicae 2.
CN2013100534254A 2013-02-19 2013-02-19 Drug for treatment of rheumatic arthritis Pending CN103100010A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN2013100534254A CN103100010A (en) 2013-02-19 2013-02-19 Drug for treatment of rheumatic arthritis
CN201310647066.5A CN103610982B (en) 2013-02-19 2013-12-04 A kind of medicine for the treatment of rheumatic arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013100534254A CN103100010A (en) 2013-02-19 2013-02-19 Drug for treatment of rheumatic arthritis

Publications (1)

Publication Number Publication Date
CN103100010A true CN103100010A (en) 2013-05-15

Family

ID=48308422

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2013100534254A Pending CN103100010A (en) 2013-02-19 2013-02-19 Drug for treatment of rheumatic arthritis
CN201310647066.5A Expired - Fee Related CN103610982B (en) 2013-02-19 2013-12-04 A kind of medicine for the treatment of rheumatic arthritis

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201310647066.5A Expired - Fee Related CN103610982B (en) 2013-02-19 2013-12-04 A kind of medicine for the treatment of rheumatic arthritis

Country Status (1)

Country Link
CN (2) CN103100010A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103393824A (en) * 2013-07-19 2013-11-20 苏州市天灵中药饮片有限公司 Traditional Chinese medicine containing radix aconiti preparata and preparation method thereof
CN103623091A (en) * 2013-12-04 2014-03-12 武瑞美 Medicament for external use for treating gout
CN104258316A (en) * 2014-10-31 2015-01-07 蔡明杰 Pharmaceutical composition for treating rheumatic arthritis and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101579434A (en) * 2008-05-15 2009-11-18 刘人源 Traditional Chinese medicine preparation for curing femoral head necrosis and vasculitis
CN101919988A (en) * 2009-06-10 2010-12-22 胡国伟 Medicine compound for curing rheumatism rheumatoid arthritis and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100368001C (en) * 2005-05-27 2008-02-13 王楚清 Medicine composition for treating rheumatic arthritis and rheumatoid arthritis, and its prepn. method
CN102526451A (en) * 2010-12-15 2012-07-04 黄启仁 Traditional Chinese medicine formula for activating tibia
CN102488879B (en) * 2011-12-22 2014-02-05 赵国辉 Medicinal composition for treating rheumatism

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101579434A (en) * 2008-05-15 2009-11-18 刘人源 Traditional Chinese medicine preparation for curing femoral head necrosis and vasculitis
CN101919988A (en) * 2009-06-10 2010-12-22 胡国伟 Medicine compound for curing rheumatism rheumatoid arthritis and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘健: "类风湿性关节炎中医药治疗进展", 《安徽中医学院学报》, vol. 17, no. 1, 31 January 1998 (1998-01-31), pages 60 - 64 *
闫翠环等: "清热解毒法治疗类风湿关节炎研究进展", 《河北中医》, vol. 28, no. 9, 30 September 2006 (2006-09-30), pages 715 - 717 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103393824A (en) * 2013-07-19 2013-11-20 苏州市天灵中药饮片有限公司 Traditional Chinese medicine containing radix aconiti preparata and preparation method thereof
CN103623091A (en) * 2013-12-04 2014-03-12 武瑞美 Medicament for external use for treating gout
CN103623091B (en) * 2013-12-04 2015-04-15 武瑞美 Medicament for external use for treating gout
CN104258316A (en) * 2014-10-31 2015-01-07 蔡明杰 Pharmaceutical composition for treating rheumatic arthritis and preparation method thereof

Also Published As

Publication number Publication date
CN103610982A (en) 2014-03-05
CN103610982B (en) 2015-07-29

Similar Documents

Publication Publication Date Title
CN103156972B (en) Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury
CN102188623A (en) Liquid plaster for treating osseous rheumatism and preparation method thereof
CN101229355B (en) Rheumatism soup
CN102488812B (en) Bone fracture oral medicine, preparation method thereof, and application method thereof
CN103705797A (en) Drug for treating kidney stones
CN103100010A (en) Drug for treatment of rheumatic arthritis
CN104000933A (en) Traditional Chinese medicine oral liquid for treating osteoproliferation
CN101912567B (en) Chinese medicinal prescription for treating chronic myocarditis
CN103989907A (en) Traditional Chinese medicine composition for treating amyloidosis cutis
CN104043067A (en) Formula of external medicinal liquor for treating bone diseases
CN104225507A (en) Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage
CN104337989A (en) Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout
CN101549141A (en) Traditional Chinese medicine for treating hysteromyoma and metrocystosis and preparation process thereof
CN111358906B (en) Traditional Chinese medicine composition suitable for exogenous diseases
CN103316228A (en) Scorpio unsting wine
CN105343705A (en) Rheumatoid arthritis treatment medicine
CN102526384B (en) Medicament for treating rheumatism and preparation method thereof
CN101439106A (en) Medicament for treating apoplexy
CN100398143C (en) Medicament for treating vitiligo
CN104547976A (en) Traditional Chinese medicinal composition for treating esophagus cancer
CN103028105B (en) Traditional Chinese medicine composition for treating headache
CN104288621A (en) Medicine for treating rheumatic arthritis
CN101874877A (en) Medicine combination for promoting blood circulation and removing blood stasis and preparation method thereof
CN101569686A (en) Hair growing hair follicle injection liquid
CN100396305C (en) Chinese medicinal preparation for treating hyperosteogeny and lumbar vertebra protrusion

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130515